146 related articles for article (PubMed ID: 8049431)
21. Ligand binding regions in the receptor for urokinase-type plasminogen activator.
Liang OD; Chavakis T; Kanse SM; Preissner KT
J Biol Chem; 2001 Aug; 276(31):28946-53. PubMed ID: 11501527
[TBL] [Abstract][Full Text] [Related]
22. A hybrid protein of urokinase growth-factor domain and plasminogen-activator inhibitor type 2 inhibits urokinase activity and binds to the urokinase receptor.
Ballance DJ; Marshall JM; Cottingham IR; Steven J; Berry SJ; Cederholm-Williams SA; Goodey AR; Courtney M
Eur J Biochem; 1992 Jul; 207(1):177-83. PubMed ID: 1321039
[TBL] [Abstract][Full Text] [Related]
23. Characterization and evolution of a gene encoding a Trimeresurus flavoviridis serum protein that inhibits basic phospholipase A2 isozymes in the snake's venom.
Nobuhisa I; Inamasu S; Nakai M; Tatsui A; Mimori T; Ogawa T; Shimohigashi Y; Fukumaki Y; Hattori S; Kihara H; Ohno M
Eur J Biochem; 1997 Nov; 249(3):838-45. PubMed ID: 9395334
[TBL] [Abstract][Full Text] [Related]
24. Urokinase-catalysed cleavage of the urokinase receptor requires an intact glycolipid anchor.
Høyer-Hansen G; Pessara U; Holm A; Pass J; Weidle U; Danø K; Behrendt N
Biochem J; 2001 Sep; 358(Pt 3):673-9. PubMed ID: 11535128
[TBL] [Abstract][Full Text] [Related]
25. Cellular glycosylphosphatidylinositol-specific phospholipase D regulates urokinase receptor shedding and cell surface expression.
Wilhelm OG; Wilhelm S; Escott GM; Lutz V; Magdolen V; Schmitt M; Rifkin DB; Wilson EL; Graeff H; Brunner G
J Cell Physiol; 1999 Aug; 180(2):225-35. PubMed ID: 10395292
[TBL] [Abstract][Full Text] [Related]
26. Glycosylation profile of a recombinant urokinase-type plasminogen activator receptor expressed in Chinese hamster ovary cells.
Ploug M; Rahbek-Nielsen H; Nielsen PF; Roepstorff P; Dano K
J Biol Chem; 1998 May; 273(22):13933-43. PubMed ID: 9593742
[TBL] [Abstract][Full Text] [Related]
27. Urokinase-type plasminogen activator is effective in fibrin clearance in the absence of its receptor or tissue-type plasminogen activator.
Bugge TH; Flick MJ; Danton MJ; Daugherty CC; Romer J; Dano K; Carmeliet P; Collen D; Degen JL
Proc Natl Acad Sci U S A; 1996 Jun; 93(12):5899-904. PubMed ID: 8650190
[TBL] [Abstract][Full Text] [Related]
28. Structural analysis of the interaction between urokinase-type plasminogen activator and its receptor: a potential target for anti-invasive cancer therapy.
Ploug M; Gårdsvoll H; Jørgensen TJ; Lønborg Hansen L; Danø K
Biochem Soc Trans; 2002 Apr; 30(2):177-83. PubMed ID: 12023847
[TBL] [Abstract][Full Text] [Related]
29. Binding of human single chain urokinase to Chinese Hamster Ovary cells and cloning of hamster u-PAR.
Fowler B; Mackman N; Parmer RJ; Miles LA
Thromb Haemost; 1998 Jul; 80(1):148-54. PubMed ID: 9684801
[TBL] [Abstract][Full Text] [Related]
30. Structure, function and expression on blood and bone marrow cells of the urokinase-type plasminogen activator receptor, uPAR.
Plesner T; Behrendt N; Ploug M
Stem Cells; 1997; 15(6):398-408. PubMed ID: 9402652
[TBL] [Abstract][Full Text] [Related]
31. Mapping part of the functional epitope for ligand binding on the receptor for urokinase-type plasminogen activator by site-directed mutagenesis.
Gårdsvoll H; Danø K; Ploug M
J Biol Chem; 1999 Dec; 274(53):37995-8003. PubMed ID: 10608868
[TBL] [Abstract][Full Text] [Related]
32. Photoaffinity labeling of the human receptor for urokinase-type plasminogen activator using a decapeptide antagonist. Evidence for a composite ligand-binding site and a short interdomain separation.
Ploug M; Ostergaard S; Hansen LB; Holm A; Danø K
Biochemistry; 1998 Mar; 37(11):3612-22. PubMed ID: 9521680
[TBL] [Abstract][Full Text] [Related]
33. Structural and phylogenetic characterization of human SLURP-1, the first secreted mammalian member of the Ly-6/uPAR protein superfamily.
Adermann K; Wattler F; Wattler S; Heine G; Meyer M; Forssmann WG; Nehls M
Protein Sci; 1999 Apr; 8(4):810-9. PubMed ID: 10211827
[TBL] [Abstract][Full Text] [Related]
34. Two alternatively spliced mouse urokinase receptor mRNAs with different histological localization in the gastrointestinal tract.
Kristensen P; Eriksen J; Blasi F; Danø K
J Cell Biol; 1991 Dec; 115(6):1763-71. PubMed ID: 1661735
[TBL] [Abstract][Full Text] [Related]
35. Functional analysis of the cellular receptor for urokinase in plasminogen activation. Receptor binding has no influence on the zymogenic nature of pro-urokinase.
Ellis V
J Biol Chem; 1996 Jun; 271(25):14779-84. PubMed ID: 8662951
[TBL] [Abstract][Full Text] [Related]
36. Characterization and function of human Ly-6/uPAR molecules.
Kong HK; Park JH
BMB Rep; 2012 Nov; 45(11):595-603. PubMed ID: 23186997
[TBL] [Abstract][Full Text] [Related]
37. Structure of the snake short-chain neurotoxin, erabutoxin c, precursor gene.
Fuse N; Tsuchiya T; Nonomura Y; Menez A; Tamiya T
Eur J Biochem; 1990 Nov; 193(3):629-33. PubMed ID: 2249684
[TBL] [Abstract][Full Text] [Related]
38. Cyclo19,31[D-Cys19]-uPA19-31 is a potent competitive antagonist of the interaction of urokinase-type plasminogen activator with its receptor (CD87).
Magdolen V; Bürgle M; de Prada NA; Schmiedeberg N; Riemer C; Schroeck F; Kellermann J; Degitz K; Wilhelm OG; Schmitt M; Kessler H
Biol Chem; 2001 Aug; 382(8):1197-205. PubMed ID: 11592401
[TBL] [Abstract][Full Text] [Related]
39. Urokinase-type plasminogen activator and its receptor synergize to promote pathogenic proteolysis.
Zhou HM; Nichols A; Meda P; Vassalli JD
EMBO J; 2000 Sep; 19(17):4817-26. PubMed ID: 10970872
[TBL] [Abstract][Full Text] [Related]
40. Carboxy-terminal processing of the urokinase receptor: implications for substrate recognition and glycosylphosphatidylinositol anchor addition.
Aceto J; Kieber-Emmons T; Cines DB
Biochemistry; 1999 Jan; 38(3):992-1001. PubMed ID: 9893995
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]